Novavax Inc vs Shopify Inc. — how do they compare? Novavax Inc trades at $8.08 (market cap $1.30B), while Shopify Inc. trades at $122.56 (market cap $161.53B). The key difference: Shopify Inc. is far larger — about 124.3× Novavax Inc's market cap. Which is the better fit depends on your goals.
| NVAX | SHOP | |
|---|---|---|
Market Cap | $1.30B | $161.53B |
Sector | Health | Technology |
52-Week High | $11.19 | $179.01 |
52-Week Low | $6.22 | $95.40 |
Enterprise Value | $800.50M | $155.97B |
Trailing returns across standard periods
Latest headlines on both assets
Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.
Read more on NVAX →Shopify Inc. provides a cloud-based commerce platform. The Company offers a platform for merchants to create an omni-channel experience that helps showcase the merchant's brand.
Read more on SHOP →